Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2 Cycles Rituximab Compared With Standard Regimen in Management of ITP

NCT02137681 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT02137681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02137681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2 Cycles Rituximab Compared With Standard Regimen in Management of ITP
Lead sponsor
Shandong University
Phase
Phase 3
Overall status
Withdrawn
Start date
May 31, 2014
Completion date
January 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia